A third of the new awards aim to accelerate cancer research, and another 25% of the new awards fund studies evaluating drug products for rare endocrine disorders.
Americans have zero immunity against the deadly H7N9 flu, and China is refusing to share much-needed samples with U.S. Researchers hoping to combat a potential outbreak.
Use of FDA-approved nicotine replacement therapy products may double the likelihood of a successful attempt to quit smoking.
Only one in four Americans believes the U.S. government’s role in funding research is irreplaceable, according to a study by ScienceCounts.
The recipient’s ultimate goal is to advance nano-bio-manufacturing methods that could lead to large-scale fabrication of functional heart tissue, which could replace diseased or damaged muscle after a heart attack.
Researchers say these results offer further evidence that a combination of this technology and rehabilitation may help patients with spinal cord injuries regain control.
The recipients of the annual Albany Medical Center Prize in Medicine and Biomedical Research are being recognized for their contributions related to the development of the tool, called CRISPR-Cas9.
The most recent new treatment for Alzheimer’s disease was approved by European regulators in May 2002, with the US FDA following suit the next year.
Researchers at the University of Pennsylvania are getting ready to test transplanting hepatitis C-infected hearts.
The possibility of curing sepsis with a common vitamin has put one of history’s greatest killers back in the spotlight.